MRNA

2024Q1BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-05-02 · Fiscal end 2024-03-31 · Features as of 2024-05-01

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-3.57
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move3.4%
IV front—
P/C full—
P/C front—
Features as of2024-05-01

Run-up

Close—
Ret 5d+2.4%
Ret 10d+7.8%
Ret 20d+10.1%
Ret 30d+6.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-3.07Beat
Estimated EPS-3.57
Actual revenue
167.0M
Surprise %+14.0%
Beat / missBeat
Beat streak 42
Beat streak 82

Reaction

1-day stock reaction+9.3%
Implied vs actual

Implied 3.4%Actual 3.1%

Gap reaction+3.1%
Day result+12.7%
Next-day upYes
Realized / IV0.90×

Post tape

Post 5d-2.3%
Post 10d+5.6%
Post volume12.0M
Vol ×10d4.25×
Vol ×20d3.99×
Post range12.8%